We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Orders Black Box Warning On 3 Insomnia Drugs After 66 Adverse Events

Mealey's (May 8, 2019, 8:39 AM EDT) -- SILVER SPRING, Md. — The Food and Drug Administration on April 30 announced that it is requiring black box warnings on three insomnia drugs after receiving 66 adverse event reports that...
To view the full article, register now.